Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,068,000 | 9,918,000 | N/A | 5,867,000 | 7,103,000 |
| Marketable Securities | 1,491,000 | 1,484,000 | N/A | 177,000 | 657,000 |
| Receivables | 10,890,000 | 7,709,000 | N/A | 6,668,000 | 5,561,000 |
| Inventories | 1,682,000 | 1,750,000 | N/A | 2,119,000 | 2,250,000 |
| Other current assets | 0 | 2,899,000 | 2,581,000 | 2,251,000 | 1,365,000 |
| TOTAL | $25,131,000 | $23,760,000 | $2,581,000 | $17,082,000 | $16,936,000 |
| Non-Current Assets | |||||
| PPE Net | 6,957,000 | 7,307,000 | N/A | 8,298,000 | 7,453,000 |
| Investments And Advances | 535,000 | 184,000 | 156,000 | 182,000 | 119,000 |
| Intangibles | 22,029,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,475,000 | 23,669,000 | 23,433,000 | 22,395,000 | 5,424,000 |
| TOTAL | $30,996,000 | $31,160,000 | $23,589,000 | $30,875,000 | $12,996,000 |
| Total Assets | $56,127,000 | $54,920,000 | $26,170,000 | $47,957,000 | $29,932,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 125,000 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 8,661,000 | 8,687,000 | 7,178,000 | 6,968,000 | 6,334,000 |
| Other current liabilities | 1,103,000 | 1,299,000 | 600,000 | 387,000 | 0 |
| TOTAL | $16,787,000 | $17,640,000 | $13,320,000 | $15,187,000 | $9,447,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,097,000 | 9,137,000 | N/A | 10,876,000 | 1,087,000 |
| Other Non-Current Liabilities | 3,660,000 | 4,075,000 | 3,423,000 | 2,997,000 | 2,535,000 |
| TOTAL | $15,930,000 | $16,459,000 | $6,549,000 | $17,992,000 | $5,181,000 |
| Total Liabilities | $32,717,000 | $34,099,000 | $19,869,000 | $33,179,000 | $14,628,000 |
| Shareholders' Equity | |||||
| Common Shares | 352,000 | 363,000 | 362,000 | 364,000 | 383,000 |
| Retained earnings | 18,272,000 | 16,198,000 | N/A | 12,002,000 | 13,250,000 |
| Other shareholders' equity | 2,114,000 | 2,080,000 | 581,000 | 524,000 | 0 |
| TOTAL | $23,410,000 | $20,821,000 | $2,989,000 | $14,778,000 | $15,304,000 |
| Total Liabilities And Equity | $56,127,000 | $54,920,000 | $22,858,000 | $47,957,000 | $29,932,000 |